Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies, ClinicoEconomics and Outcomes Research, January 2015, Taylor & Francis,
DOI: 10.2147/ceor.s69981.
You can read the full text:
Contributors
The following have contributed to this page
